Reproducibility studies were performed using two FFPE glioma samples, cases 8 and 22, with IDH1 p.R132H and IDH2 p.R172K mutations respectively, by testing FFPE sections on three separate days (Supplementary Table 5). The gene discussed is IDH2; the disease is central nervous system cancer.